Ayman Saad

BMT/Cell Therapy. KFSHRC (Riyadh, Saudi Arabia). Ex-Professor, Ohio State University

[Shernan Holtan MD @sghmd]

TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study. https://t.co/j3JsNd7ruy

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

A moment of pride! A co-first author in the best journal in medicine for a clinical trial that resulted in FDA approval in the USA and is changing how we treat acute myeloid leukemia #AMLsm. Congratulations to all the authors لحظة فخر! باحث أول مشارك في أفضل مجلة علمية في الطب لتجربة إكلينيكية أدت إلى موافقة إدارة الغذاء والدواء الأمريكية وتغير الطريقة التي نعالج بها اللوكيميا النخاعية الحادة.

[Ayman Saad @aymansaadOSU]

@VincentRK @marklewismd @Rfonsi1 And all authors are from manufacturing company underscoring the Pharma partnership in our mission! Great work 👌

[Ayman Saad @aymansaadOSU]

@DrBattiwalla Thank you @DrBattiwalla for the great summary 👌

[Mohamad Mohty @Mohty_EBMT]

MAJESTEC-9 trial at #ASCO26 : the message was strikingly simple: a couple of curves summarized it all. At the end, curves speak louder than words. @TheIACH @COMyCongress

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Outstanding contribution led by Dr @IvanCivettini and the Humanitas team published in @NEJMEvidence which we at @YaleCancer were happy to be a part of it! Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution | NEJM Evidence https://t.co/VtNUJVRoqh

[Eric Topol @EricTopol]

Just published @NEJM
Marked and durable reduction of LDL cholesterol with one shot PCSK9 gene base editing @skathire https://t.co/3fU9EjatjH

[Ayman Saad @aymansaadOSU]

@AhmedTaherMD @Philips @RadiologyACR @RLI_ACR @UTHradiology Congratulations 🎉 Ahmed!

[Joseph (Joe) Maakaron @JMaakaron]

Exciting times for heme malignancies!

Sonrotoclax approved for r/r MCL and Inqovi/Ven approved for AML!

#lymsm #leusm

[CancerNetwork® @CancerNetwrk]

🚨 The FDA approved oral decitabine and cedazuridine tablets with venetoclax for newly diagnosed AML in adults ≥75 years, or who have comorbidities that preclude the use of intensive induction chemotherapy.

https://t.co/z8MRDvataW

#leusm #AML #leukemia #oncology | @FDAOncology

[Ayman Saad @aymansaadOSU]

@Abdallah81MD @AlmaHabibMD Very nice @AlmaHabibMD

[Ayman Saad @aymansaadOSU]

@DrMarcosdelima @AnnaSureda5 @MillyValverde1 @OSUWexMed Congratulations @MillyValverde99

[Ayman Saad @aymansaadOSU]

Nice EBMT webinar on sickle/Hbpathy with our ⁦@Ruah_Mahmoud⁩ 👌⁦@KFSHRC_Research⁩ https://t.co/SO7ryELwFZ

[Abdel-Wahab Lab @AbdelWahablab]

Excited to announce a new paper out now in @CD_AACR on a unique CAR T cell platform that eliminates AML and B-ALL without harming vital endogenous immune cells or other normal human tissues:
https://t.co/IVb5KIYqMs

[David Daines @daviddorg]

Stanford paid 35,000 people to quit Facebook and Instagram for 6 weeks

Depression dropped. Anxiety dropped. Happiness went up. Women under 25 on Instagram saw the biggest gains

That was 6 weeks. I'm going a full year.

[Ayman Saad @aymansaadOSU]

@OSUHematology @beatalleukemia @OSUCCC_James Most would team on the earth! 👌👌

[Ayman Saad @aymansaadOSU]

@VincentRK @ACPIMPhysicians @AnnalsofIM Does it really matter that much?! 😱

[Ayman Saad @aymansaadOSU]

@jorgecortesmd @uabmedicine @ONealCancerUAB @icmlf @ASH_hematology @BloodGlobalHema Congratulations @jorgecortesmd
I recall that day for me in July 2012 before beautiful 6 years, I spend in sweet home, Alabama 👌

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Excited to join colleagues in NYC  this July 11-12 for the 10th Annual Live Medical Crossfire®: Hematologic Malignancies. This year’s program will focus on navigating complex cases, new therapeutic approaches, and practical strategies you can take back to your clinic. Use code ZEIDAN for free HCP registration.
✅ Join us and register today: https://t.co/cd0rJfD2vk
@gotoper_
#MedicalCrossfire #gotoPER #Hematology #Oncology #CancerCare

[Mohamad Mohty @Mohty_EBMT]

An inspiring superb lecture by @DrHKantarjian⁩ on how to define cure in leukemia . ⁦@Myeloma_Society⁩ ⁦@COMyCongress⁩ ⁦@TheIACH⁩